Loading provider…
Loading provider…
Hematology & Oncology Physician in Mount Pleasant, SC
NPI: 1396729414Primary Practice Location
MUSC Physicians PC
1208 Island Ct, Mount Pleasant, SC
Primary Employer
MUSC Physicians
muschealth.org
HQ Phone
Get MD Steven's Phone NumberMobile
Get MD Steven's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License
SC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 68 | 108 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 41 | 90 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 36 | 36 |
G4 resolvase 1 tightly binds and unwinds unimolecular G4-DNA.
Authors: Giri, Banabihari, Smaldino, Philip J, Thys, Ryan G, Creacy, Steven D, Routh, Eric D, Hantgan, Roy R, Lattmann, Simon, Nagamine, Yoshikuni, Akman, Steven A, Vaughn, James P
Journal: Nucleic Acids Res
Publication Date: 2011-05-17
The core control system of intracellular iron homeostasis: a mathematical model.
Authors: Chifman, J, Kniss, A, Neupane, P, Williams, I, Leung, B, Deng, Z, Mendes, P, Hower, V, Torti, F M, Akman, S A, Torti, S V, Laubenbacher, R
Journal: J Theor Biol
Publication Date: 2012-01-23
Authors: Lawrence, Julia A, Akman, Steven A, Melin, Susan A, Case, L Douglas, Schwartz, Gary G
Journal: Cancer Biol Ther
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Temozolomide, OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, DRUG: Veliparib, OTHER: Placebo Administration
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, BIOLOGICAL: Nivolumab, OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Ipilimumab, OTHER: Quality-of-Life Assessment
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, BIOLOGICAL: Pembrolizumab, BIOLOGICAL: Ipilimumab, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, PROCEDURE: Computed Tomography, BIOLOGICAL: Recombinant Interferon Alfa-2b